ASPROSIN AS A NOVEL BIOMARKER FOR HEART FAILURE: DIAGNOSTIC VALUE AND ASSOCIATION WITH CARDIAC FUNCTION PARAMETERS
Esraa S. Al-Fatlawey
Objective: Heart failure (HF) is an expanding global health issue, impacting millions of people worldwide. Type II diabetes mellitus and polycystic ovarian syndrome are metabolic illness that are linked to asprosin, a newly discovered fasting...